BACKGROUND AND PURPOSE: The risk of intracranial aneurysm (IA) rupture in asymptomatic members of families who have multiple affected individuals is not known. METHODS: First-degree unaffected relatives of those with a familial history of IA who had a history of smoking or hypertension but no known IA were offered cerebral MR angiography (MRA) and followed yearly as part of a National Institute of Neurological Diseases and Stroke-funded study of familial IA (Familial Intracranial Aneurysm [FIA] Study). RESULTS: A total of 2874 subjects from 542 FIA Study families were enrolled. After study enrollment, MRAs were performed in 548 FIA Study family members with no known history of IA. Of these 548 subjects, 113 subjects (20.6%) had 148 IAs by MRA of whom 5 subjects had IA >or=7 mm. Two subjects with an unruptured IA by MRA/CT angiography (3-mm and 4-mm anterior communicating artery) subsequently had rupture of their IA. This represents an annual rate of 1.2 ruptures per 100 subjects (1.2% per year; 95% CI, 0.14% to 4.3% per year). None of the 435 subjects with a negative MRA have had a ruptured IA. Survival curves between the MRA-positive and -negative cohorts were significantly different (P=0.004). This rupture rate of unruptured IA in the FIA Study cohort of 1.2% per year is approximately 17 times higher than the rupture rate for subjects with an unruptured IA in the International Study of Unruptured Aneurysm Study with a matched distribution of IA size and location 0.069% per year. CONCLUSIONS: Small unruptured IAs in patients from FIA Study families may have a higher risk of rupture than sporadic unruptured IAs of similar size, which should be considered in the management of these patients.
BACKGROUND AND PURPOSE: The risk of intracranial aneurysm (IA) rupture in asymptomatic members of families who have multiple affected individuals is not known. METHODS: First-degree unaffected relatives of those with a familial history of IA who had a history of smoking or hypertension but no known IA were offered cerebral MR angiography (MRA) and followed yearly as part of a National Institute of Neurological Diseases and Stroke-funded study of familial IA (Familial Intracranial Aneurysm [FIA] Study). RESULTS: A total of 2874 subjects from 542 FIA Study families were enrolled. After study enrollment, MRAs were performed in 548 FIA Study family members with no known history of IA. Of these 548 subjects, 113 subjects (20.6%) had 148 IAs by MRA of whom 5 subjects had IA >or=7 mm. Two subjects with an unruptured IA by MRA/CT angiography (3-mm and 4-mm anterior communicating artery) subsequently had rupture of their IA. This represents an annual rate of 1.2 ruptures per 100 subjects (1.2% per year; 95% CI, 0.14% to 4.3% per year). None of the 435 subjects with a negative MRA have had a ruptured IA. Survival curves between the MRA-positive and -negative cohorts were significantly different (P=0.004). This rupture rate of unruptured IA in the FIA Study cohort of 1.2% per year is approximately 17 times higher than the rupture rate for subjects with an unruptured IA in the International Study of Unruptured Aneurysm Study with a matched distribution of IA size and location 0.069% per year. CONCLUSIONS: Small unruptured IAs in patients from FIA Study families may have a higher risk of rupture than sporadic unruptured IAs of similar size, which should be considered in the management of these patients.
Authors: Anna Helgadottir; Gudmar Thorleifsson; Kristinn P Magnusson; Solveig Grétarsdottir; Valgerdur Steinthorsdottir; Andrei Manolescu; Gregory T Jones; Gabriel J E Rinkel; Jan D Blankensteijn; Antti Ronkainen; Juha E Jääskeläinen; Yoshiki Kyo; Guy M Lenk; Natzi Sakalihasan; Konstantinos Kostulas; Anders Gottsäter; Andrea Flex; Hreinn Stefansson; Torben Hansen; Gitte Andersen; Shantel Weinsheimer; Knut Borch-Johnsen; Torben Jorgensen; Svati H Shah; Arshed A Quyyumi; Christopher B Granger; Muredach P Reilly; Harland Austin; Allan I Levey; Viola Vaccarino; Ebba Palsdottir; G Bragi Walters; Thorbjorg Jonsdottir; Steinunn Snorradottir; Dana Magnusdottir; Gudmundur Gudmundsson; Robert E Ferrell; Sigurlaug Sveinbjornsdottir; Juha Hernesniemi; Mika Niemelä; Raymond Limet; Karl Andersen; Gunnar Sigurdsson; Rafn Benediktsson; Eric L G Verhoeven; Joep A W Teijink; Diederick E Grobbee; Daniel J Rader; David A Collier; Oluf Pedersen; Roberto Pola; Jan Hillert; Bengt Lindblad; Einar M Valdimarsson; Hulda B Magnadottir; Cisca Wijmenga; Gerard Tromp; Annette F Baas; Ynte M Ruigrok; Andre M van Rij; Helena Kuivaniemi; Janet T Powell; Stefan E Matthiasson; Jeffrey R Gulcher; Gudmundur Thorgeirsson; Augustine Kong; Unnur Thorsteinsdottir; Kari Stefansson Journal: Nat Genet Date: 2008-01-06 Impact factor: 38.330
Authors: E S Connolly; T F Choudhri; W J Mack; J Mocco; T J Spinks; J Slosberg; T Lin; J Huang; R A Solomon Journal: Neurosurgery Date: 2001-01 Impact factor: 4.654
Authors: Kaya Bilguvar; Katsuhito Yasuno; Mika Niemelä; Ynte M Ruigrok; Mikael von Und Zu Fraunberg; Cornelia M van Duijn; Leonard H van den Berg; Shrikant Mane; Christopher E Mason; Murim Choi; Emília Gaál; Yasar Bayri; Luis Kolb; Zulfikar Arlier; Sudhakar Ravuri; Antti Ronkainen; Atsushi Tajima; Aki Laakso; Akira Hata; Hidetoshi Kasuya; Timo Koivisto; Jaakko Rinne; Juha Ohman; Monique M B Breteler; Cisca Wijmenga; Matthew W State; Gabriel J E Rinkel; Juha Hernesniemi; Juha E Jääskeläinen; Aarno Palotie; Ituro Inoue; Richard P Lifton; Murat Günel Journal: Nat Genet Date: 2008-11-09 Impact factor: 38.330
Authors: David O Wiebers; J P Whisnant; J Huston; I Meissner; R D Brown; D G Piepgras; G S Forbes; K Thielen; D Nichols; W M O'Fallon; J Peacock; L Jaeger; N F Kassell; G L Kongable-Beckman; J C Torner Journal: Lancet Date: 2003-07-12 Impact factor: 79.321
Authors: Robert D Brown; John Huston; Richard Hornung; Tatiana Foroud; David F Kallmes; Dawn Kleindorfer; Irene Meissner; Daniel Woo; Laura Sauerbeck; Joseph Broderick Journal: J Neurosurg Date: 2008-06 Impact factor: 5.115
Authors: Joseph P Broderick; Laura R Sauerbeck; Tatiana Foroud; John Huston; Nathan Pankratz; Irene Meissner; Robert D Brown Journal: BMC Med Genet Date: 2005-04-26 Impact factor: 2.103
Authors: Juan R Cebral; Xinjie Duan; Piyusha S Gade; Bong Jae Chung; Fernando Mut; Khaled Aziz; Anne M Robertson Journal: Ann Biomed Eng Date: 2016-06-27 Impact factor: 3.934
Authors: Oliver M Mueller; Marc Schlamann; Daniela Mueller; I Erol Sandalcioglu; Michael Forsting; Ulrich Sure Journal: Ther Adv Neurol Disord Date: 2011-09 Impact factor: 6.570
Authors: Anne M Robertson; Xinjie Duan; Khaled M Aziz; Michael R Hill; Simon C Watkins; Juan R Cebral Journal: Ann Biomed Eng Date: 2015-01-30 Impact factor: 3.934
Authors: Ingeborg Rasing; Ynte M Ruigrok; Paut Greebe; Birgitta K Velthuis; Theo D Witkamp; Marieke J H Wermer; Yvo B Roos; W Peter Vandertop; Gabriel J E Rinkel Journal: Neurology Date: 2015-01-30 Impact factor: 9.910